ARS Pharmaceuticals, Inc. (SPRY) — Analyst estimates
Consensus analyst estimates for ARS Pharmaceuticals, Inc. — earnings, revenue, and price targets.
| Fiscal Year | Revenue Forecast | EPS Forecast | analysts |
|---|---|---|---|
| 2026 | 40.98M | -0.39 | 1 |
| 2027 | 77.47M | -0.21 | 1 |
| 2028 | 123.01M | 0.16 | 1 |
| 2029 | 585.84M | 0.57 | 2 |
| 2030 | 638.63M | 0.69 | 2 |
Consensus analyst estimates by fiscal year.